These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32613429)

  • 1. A Cautionary Tale: Quantitative LC-HRMS Analytical Procedures for the Analysis of N-Nitrosodimethylamine in Metformin.
    Yang J; Marzan TA; Ye W; Sommers CD; Rodriguez JD; Keire DA
    AAPS J; 2020 Jul; 22(4):89. PubMed ID: 32613429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin drugs under simulated gastric conditions can generate high nitrite-dependent levels of N-nitrosodimethylamine.
    Georgescu GC; Cretu-Stancu M; Bucur O
    Sci Rep; 2024 Jun; 14(1):13910. PubMed ID: 38886399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines.
    Keire DA; Bream R; Wollein U; Schmaler-Ripcke J; Burchardt A; Conti M; Zmysłowski A; Keizers P; Morin J; Poh J; George M; Wierer M
    AAPS J; 2022 Apr; 24(3):56. PubMed ID: 35449372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A GC-MS/MS Method for Trace Level Quantification of Six Nitrosamine Impurities (NDMA, NDEA, NEIPA, NDIPA, NDPA, and NDBA) in Commercially Used Organic Solvents: Dichloromethane, Ethyl Acetate, Toluene, and O-xylene.
    Kosuri ER; Bhanti M; Jaywant MA; Han M; Wang X; Obeng M
    J Pharm Sci; 2023 May; 112(5):1225-1230. PubMed ID: 36462706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of low molecular weight nitrosamines in pharmaceutical products by fast gas chromatography mass spectrometry.
    Kalauz A; Tiringer KV; Horváth V; Kapui I
    J Chromatogr A; 2023 Oct; 1708():464323. PubMed ID: 37696123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient In-Use Stability Testing of FDA-Approved Metformin Combination Products for N-Nitrosamine Impurity.
    Dharani S; Mohamed EM; Rahman Z; Khan MA
    AAPS PharmSciTech; 2024 Jan; 25(1):19. PubMed ID: 38267707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of eight nitrosamines in water at the ng L(-1) levels by liquid chromatography coupled to atmospheric pressure chemical ionization tandem mass spectrometry.
    Ripollés C; Pitarch E; Sancho JV; López FJ; Hernández F
    Anal Chim Acta; 2011 Sep; 702(1):62-71. PubMed ID: 21819861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Full Evaporation Static Headspace Gas Chromatography Method with Nitrogen Phosphorous Detection for Ultrasensitive Analysis of Semi-volatile Nitrosamines in Pharmaceutical Products.
    Zheng J; Kirkpatrick CL; Lee D; Han X; Martinez AI; Gallagher K; Evans RK; Mudur SV; Liang X; Drake J; Buhler LA; Mowery MD
    AAPS J; 2022 Jan; 24(1):23. PubMed ID: 34993666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of genotoxic N-nitrosamines in active pharmaceutical ingredients and market authorized products in low abundance by means of liquid chromatography - tandem mass spectrometry.
    Vogel M; Norwig J
    J Pharm Biomed Anal; 2022 Sep; 219():114910. PubMed ID: 35779354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contamination of valsartan and other sartans, part 1: New findings.
    Sörgel F; Kinzig M; Abdel-Tawab M; Bidmon C; Schreiber A; Ermel S; Wohlfart J; Besa A; Scherf-Clavel O; Holzgrabe U
    J Pharm Biomed Anal; 2019 Aug; 172():395-405. PubMed ID: 31122801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of dispersive inclusion complex microextraction for the analysis of nitrosamines in medicinal products.
    Tay KSJ; Breadmore MC; Soh ES; See HH
    J Chromatogr A; 2022 Dec; 1685():463605. PubMed ID: 36375217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NDMA analytics in metformin products: Comparison of methods and pitfalls.
    Fritzsche M; Blom G; Keitel J; Goettsche A; Seegel M; Leicht S; Guessregen B; Hickert S; Reifenberg P; Cimelli A; Baranowski R; Desmartin E; Barrau E; Harrison M; Bristow T; O'Neill N; Kirsch A; Krueger P; Saal C; Mouton B; Schlingemann J
    Eur J Pharm Sci; 2022 Jan; 168():106026. PubMed ID: 34597792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NDMA impurity in valsartan and other pharmaceutical products: Analytical methods for the determination of N-nitrosamines.
    Parr MK; Joseph JF
    J Pharm Biomed Anal; 2019 Feb; 164():536-549. PubMed ID: 30458387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multi-Analyte LC-MS/MS Method for Determination and Quantification of Six Nitrosamine Impurities in Sartans like Azilsartan, Valsartan, Telmisartan, Olmesartan, Losartan and Irbesartan.
    Gopireddy RR; Maruthapillai A; Mahapatra S
    J Chromatogr Sci; 2024 Feb; 62(2):147-167. PubMed ID: 35830866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Carcinogenic Impurities of N-Nitrosamines in Sartan Pharmaceutical Products Marketed in Brazil: Development and Validation of Method Based on High-Performance Liquid Chromatography-Tandem Mass Spectrometry.
    Monteiro MA; de Lima PC; Novotny TS; Santana DS; Lima MED; Dantas ASCL; Ferreira LODS; de Souza MN; Maranho RLDN; Ochs SM
    J Pharm Sci; 2023 May; 112(5):1305-1314. PubMed ID: 36657719
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zmysłowski A; Książek I; Szterk A
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33202951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Quantitation of Four Nitrosamine Impurities in Angiotensin Receptor Blocker Drug Substances.
    Zhang J; Selaya SD; Shakleya D; Mohammad A; Faustino PJ
    J Pharm Sci; 2023 May; 112(5):1246-1254. PubMed ID: 36509171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of N-nitrosodimethylamine from drug substances using solid-phase extraction-liquid chromatography-tandem mass spectrometry.
    Yamamoto E; Kan-No H; Tomita N; Ando D; Miyazaki T; Izutsu KI
    J Pharm Biomed Anal; 2022 Feb; 210():114561. PubMed ID: 34974238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into the formation of N-nitrosodimethylamine in metformin products.
    Jireš J; Kalášek S; Gibala P; Rudovský J; Douša M; Kubelka T; Hrubý J; Řezanka P
    J Pharm Biomed Anal; 2021 Feb; 195():113877. PubMed ID: 33422831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the current status and prospects of nitrosation pathways and possible root causes of nitrosamine formation in various pharmaceuticals.
    Wichitnithad W; Nantaphol S; Noppakhunsomboon K; Rojsitthisak P
    Saudi Pharm J; 2023 Feb; 31(2):295-311. PubMed ID: 36942272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.